Trial intelligence / Profile preview

Hypertonic Saline Dextran in Pediatric Cardiac Surgery

NCT00199771Phase 2Completed

Sponsor
Oslo University Hospital
Start
Jun 2003
Primary completion
Dec 2004
Modality
Polymer-based Nanoparticles
01

Overview

A Phase 2 trial of dextran-70 in congenital heart defects (CHD), sponsored by Oslo University Hospital. Started Jun 2003; status: completed.

02

Drugs

dextran-70
03

Conditions

congenital heart defects (CHD)

Beyond the preview

Go deeper on NCT00199771.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00199771.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call